Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Intraoperative Ultrasound Guidance in Breast-Conserving Surgery Improves Cosmetic Outcomes and Patient Satisfaction: Results of a Multicenter Randomized Controlled Trial (COBALT).

Haloua MH, Volders JH, Krekel NM, Lopes Cardozo AM, de Roos WK, de Widt-Levert LM, van der Veen H, Rijna H, Bergers E, Jóźwiak K, Meijer S, van den Tol P.

Ann Surg Oncol. 2016 Jan;23(1):30-7.

2.

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).

Saadatmand S, Obdeijn IM, Rutgers EJ, Oosterwijk JC, Tollenaar RA, Woldringh GH, Bergers E, Verhoef C, Heijnsdijk EA, Hooning MJ, de Koning HJ, Tilanus-Linthorst MM.

Int J Cancer. 2015 Oct 1;137(7):1729-38. doi: 10.1002/ijc.29534. Epub 2015 Apr 17.

3.

Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicentre, randomised controlled trial.

Krekel NM, Haloua MH, Lopes Cardozo AM, de Wit RH, Bosch AM, de Widt-Levert LM, Muller S, van der Veen H, Bergers E, de Lange de Klerk ES, Meijer S, van den Tol MP.

Lancet Oncol. 2013 Jan;14(1):48-54. doi: 10.1016/S1470-2045(12)70527-2. Epub 2012 Dec 4.

PMID:
23218662
4.

[Breast-conserving surgery for breast cancer: still much to be gained].

Krekel NM, Haloua MH, Muller S, Bergers E, Rietveld DH, Meijers S, van den Tol MP.

Ned Tijdschr Geneeskd. 2012;156(29):A3573. Dutch.

PMID:
22831490
5.

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.

Heijnsdijk EA, Warner E, Gilbert FJ, Tilanus-Linthorst MM, Evans G, Causer PA, Eeles RA, Kaas R, Draisma G, Ramsay EA, Warren RM, Hill KA, Hoogerbrugge N, Wasser MN, Bergers E, Oosterwijk JC, Hooning MJ, Rutgers EJ, Klijn JG, Plewes DB, Leach MO, de Koning HJ.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1458-68. doi: 10.1158/1055-9965.EPI-11-1196. Epub 2012 Jun 28.

6.

[Ultrasonically guided breast-conserving surgery for palpable mammary tumours].

Krekel NM, van Amerongen AH, Bergers E, Meijer S, van den Tol P.

Ned Tijdschr Geneeskd. 2012;156(10):A4173. Dutch.

PMID:
22394444
7.

Optimising surgical accuracy in palpable breast cancer with intra-operative breast ultrasound--feasibility and surgeons' learning curve.

Krekel NM, Lopes Cardozo AM, Muller S, Bergers E, Meijer S, van den Tol MP.

Eur J Surg Oncol. 2011 Dec;37(12):1044-50. doi: 10.1016/j.ejso.2011.08.127. Epub 2011 Sep 15.

PMID:
21924854
8.

Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomised controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial).

Krekel NM, Zonderhuis BM, Schreurs HW, Cardozo AM, Rijna H, van der Veen H, Muller S, Poortman P, de Widt L, de Roos WK, Bosch AM, Taets van Amerongen AH, Bergers E, van der Linden MH, de Lange de Klerk ES, Winters HA, Meijer S, van den Tol PM.

BMC Surg. 2011 Mar 16;11:8. doi: 10.1186/1471-2482-11-8.

9.

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.

Rijnsburger AJ, Obdeijn IM, Kaas R, Tilanus-Linthorst MM, Boetes C, Loo CE, Wasser MN, Bergers E, Kok T, Muller SH, Peterse H, Tollenaar RA, Hoogerbrugge N, Meijer S, Bartels CC, Seynaeve C, Hooning MJ, Kriege M, Schmitz PI, Oosterwijk JC, de Koning HJ, Rutgers EJ, Klijn JG.

J Clin Oncol. 2010 Dec 20;28(36):5265-73. doi: 10.1200/JCO.2009.27.2294. Epub 2010 Nov 15.

PMID:
21079137
10.

Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition.

Obdeijn IM, Loo CE, Rijnsburger AJ, Wasser MN, Bergers E, Kok T, Klijn JG, Boetes C.

Breast Cancer Res Treat. 2010 Jan;119(2):399-407. doi: 10.1007/s10549-009-0607-7.

PMID:
19876732
11.

Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis.

Korteweg T, Uitdehaag BM, Knol DL, Smithuis RH, Algra PR, de Vries C, Poppe PA, van Waesberghe JH, Bergers E, Lycklama à Nijeholt GJ, Polman CH, Barkhof F.

Eur Radiol. 2007 Jan;17(1):67-71. Epub 2006 May 18.

PMID:
16708216
12.

Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.

Lazeron RH, Boringa JB, Schouten M, Uitdehaag BM, Bergers E, Lindeboom J, Eikelenboom MI, Scheltens PH, Barkhof F, Polman CH.

Mult Scler. 2005 Oct;11(5):524-31.

PMID:
16193889
13.

The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results.

Bot JC, Blezer EL, Kamphorst W, Lycklama A Nijeholt GJ, Ader HJ, Castelijns JA, Ig KN, Bergers E, Ravid R, Polman C, Barkhof F.

Radiology. 2004 Nov;233(2):531-40. Epub 2004 Sep 22.

PMID:
15385682
14.

Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Bot JC, Barkhof F, Polman CH, Lycklama à Nijeholt GJ, de Groot V, Bergers E, Ader HJ, Castelijns JA.

Neurology. 2004 Jan 27;62(2):226-33.

PMID:
14745058
15.

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, Polman CH, van der Valk P.

Arch Neurol. 2003 Aug;60(8):1073-81.

PMID:
12925362
16.

The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.

Kalkers NF, Barkhof F, Bergers E, van Schijndel R, Polman CH.

Mult Scler. 2002 Dec;8(6):532-3.

PMID:
12474997
17.

Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions.

Bergers E, Bot JC, De Groot CJ, Polman CH, Lycklama à Nijeholt GJ, Castelijns JA, van der Valk P, Barkhof F.

Neurology. 2002 Dec 10;59(11):1766-71.

PMID:
12473766
18.

Diffuse signal abnormalities in the spinal cord in multiple sclerosis: direct postmortem in situ magnetic resonance imaging correlated with in vitro high-resolution magnetic resonance imaging and histopathology.

Bergers E, Bot JC, van der Valk P, Castelijns JA, Lycklama a Nijeholt GJ, Kamphorst W, Polman CH, Blezer EL, Nicolay K, Ravid R, Barkhof F.

Ann Neurol. 2002 May;51(5):652-6.

PMID:
12112117
19.

Magnetic resonance imaging of injected silicone: findings in seven male-to-female transsexuals.

Oen AL, Bergers E, Kanhai R, Hage JJ, Manoliu RA.

Eur Radiol. 2002 May;12(5):1221-7. Epub 2001 Nov 24.

PMID:
11976871
20.

Optimizing the association between disability and biological markers in MS.

Kalkers NF, Bergers E, Castelijns JA, van Walderveen MA, Bot JC, Adèr HJ, Polman CH, Barkhof F.

Neurology. 2001 Oct 9;57(7):1253-8.

PMID:
11591845
21.

Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions.

De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, van der Valk P.

Brain. 2001 Aug;124(Pt 8):1635-45.

PMID:
11459754
22.

Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype.

Nijeholt GJ, Bergers E, Kamphorst W, Bot J, Nicolay K, Castelijns JA, van Waesberghe JH, Ravid R, Polman CH, Barkhof F.

Brain. 2001 Jan;124(Pt 1):154-66.

PMID:
11133795
23.

Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis.

Bot JC, Barkhof F, Lycklama à Nijeholt GJ, Bergers E, Polman CH, Adèr HJ, Castelijns JA.

Eur Radiol. 2000;10(5):753-8.

PMID:
10823627
24.

Spinal cord magnetic resonance imaging in suspected multiple sclerosis.

Lycklama à Nijeholt GJ, Uitdehaag BM, Bergers E, Castelijns JA, Polman CH, Barkhof F.

Eur Radiol. 2000;10(2):368-76.

PMID:
10663771
25.

Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.

Bergers E, Baak JP, van Diest PJ, Willig AJ, Los J, Peterse JL, Ruitenberg HM, Schapers RF, Somsen JG, van Beek MW, Bellot SM, Fijnheer J, van Gorp LH.

Mod Pathol. 1997 Aug;10(8):762-8.

PMID:
9267817
26.

Reliable DNA histogram interpretation. Number of nuclei requiring measurement with flow cytometry.

Bergers E, van Diest PJ, Baak JP.

Anal Quant Cytol Histol. 1997 Aug;19(4):277-84.

PMID:
9267560
27.

Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: results from the Multicenter Morphometric Mammary Carcinoma Project (MMMCP).

Bergers E, Baak JP, van Diest PJ, van Gorp LH, Kwee WS, Los J, Peterse HL, Ruitenberg HM, Schapers RF, Somsen JG, van Beek MW, Bellot SM, Fijnheer J.

Int J Cancer. 1997 Jun 20;74(3):260-9.

28.
29.

The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables.

Bergers E, Jannink I, van Diest PI, Cuesta MA, Meyer S, van Mourik JC, Baak JP.

Hum Pathol. 1997 Jan;28(1):95-100.

PMID:
9013839
30.

Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry.

Bergers E, van Diest PJ, Baak JP.

J Clin Pathol. 1996 Nov;49(11):931-7.

31.
33.
34.

Quantitative microscopical and confocal laser scanning microscopy for intermediate endpoint biomarkers in breast cancer: potential and reproducibility.

Baak JP, Makkink-Nombrado S, Tekola P, Bergers E, Beliën JA, van Ginkel AH.

J Cell Biochem Suppl. 1993;17G:98-106. Review.

PMID:
8007717

Supplemental Content

Loading ...
Support Center